# Innodata Inc: financial statements, quarterly

INOD · Nasdaq · CIK 903651 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/inod.md) · [Financials](/companies/inod/financials.md) · [Filings](/companies/inod/filings.md) · [Insiders](/companies/inod/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/inod/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [22.2](/filings/0001410578-24-001800.md) | [26.1 d](/filings/0001410578-25-000194.md) | [26.5](/filings/0001410578-25-001113.md) | [32.6](/filings/0001410578-25-001550.md) | [52.2](/filings/0001104659-25-107873.md) | [59.2 d](/filings/0001104659-26-020655.md) | [58.3](/filings/0001104659-26-057270.md) | [58.4](/filings/0001104659-26-092021.md) | [62.6](/filings/0001104659-25-107873.md) | [72.4 d](/filings/0001104659-26-020655.md) | [90.1](/filings/0001104659-26-057270.md) | [92.1](/filings/0001104659-26-092021.md) |
| Gross profit | $m | not reported | not reported | [9.6](/filings/0001410578-25-001113.md) | [9.4](/filings/0001410578-25-001550.md) | [21.3](/filings/0001104659-25-107873.md) | [26.8 d](/filings/0001104659-26-020655.md) | [23.3](/filings/0001410578-25-001113.md) | [23.0](/filings/0001410578-25-001550.md) | [25.5](/filings/0001104659-25-107873.md) | [27.7 d](/filings/0001104659-26-020655.md) | not reported | not reported |
| Selling, general and administrative | $m | [7.4](/filings/0001410578-24-001800.md) | [8.2 d](/filings/0001410578-25-000194.md) | [8.3](/filings/0001410578-25-001113.md) | [9.0](/filings/0001410578-25-001550.md) | [9.9](/filings/0001104659-25-107873.md) | [15.5 d](/filings/0001104659-26-020655.md) | [15.0](/filings/0001104659-26-057270.md) | [14.1](/filings/0001104659-26-092021.md) | [13.7](/filings/0001104659-25-107873.md) | [16.8 d](/filings/0001104659-26-020655.md) | [22.9](/filings/0001104659-26-057270.md) | [26.6](/filings/0001104659-26-092021.md) |
| Operating income | $m | not reported | not reported | [1.3](/filings/0001410578-25-001113.md) | [0.3](/filings/0001410578-25-001550.md) | [11.4](/filings/0001104659-25-107873.md) | [11.3 d](/filings/0001104659-26-020655.md) | [8.3](/filings/0001410578-25-001113.md) | [8.9](/filings/0001410578-25-001550.md) | [11.8](/filings/0001104659-25-107873.md) | [10.9 d](/filings/0001104659-26-020655.md) | not reported | not reported |
| Income tax | $m | [0.4](/filings/0001410578-24-001800.md) | [0.2 d](/filings/0001410578-25-000194.md) | [0.4](/filings/0001410578-25-001113.md) | [0.3](/filings/0001410578-25-001550.md) | [(5.9)](/filings/0001104659-25-107873.md) | [1.0 d](/filings/0001104659-26-020655.md) | [0.6](/filings/0001104659-26-057270.md) | [2.3](/filings/0001104659-26-092021.md) | [3.8](/filings/0001104659-25-107873.md) | [2.5 d](/filings/0001104659-26-020655.md) | [2.4](/filings/0001104659-26-057270.md) | [3.1](/filings/0001104659-26-092021.md) |
| Net income | $m | [0.4](/filings/0001410578-24-001800.md) | [1.6 d](/filings/0001410578-25-000194.md) | [1.0](/filings/0001104659-25-107873.md) | [(0.0)](/filings/0001104659-25-107873.md) | [17.4](/filings/0001104659-25-107873.md) | [10.3 d](/filings/0001104659-26-020655.md) | [7.8](/filings/0001104659-26-092021.md) | [7.2](/filings/0001104659-26-092021.md) | [8.3](/filings/0001104659-25-107873.md) | [8.8 d](/filings/0001104659-26-020655.md) | [14.9](/filings/0001104659-26-092021.md) | [14.4](/filings/0001104659-26-092021.md) |
| Diluted EPS | $ per share | [0.01](/filings/0001410578-24-001800.md) | not reported | [0.03](/filings/0001410578-25-001113.md) | [0.00](/filings/0001410578-25-001550.md) | [0.51](/filings/0001104659-25-107873.md) | not reported | [0.22](/filings/0001104659-26-057270.md) | [0.20](/filings/0001104659-26-092021.md) | [0.24](/filings/0001104659-25-107873.md) | not reported | [0.42](/filings/0001104659-26-057270.md) | [0.41](/filings/0001104659-26-092021.md) |
| Basic EPS | $ per share | [0.01](/filings/0001410578-24-001800.md) | not reported | [0.03](/filings/0001410578-25-001113.md) | [0.00](/filings/0001410578-25-001550.md) | [0.60](/filings/0001104659-25-107873.md) | not reported | [0.25](/filings/0001104659-26-057270.md) | [0.23](/filings/0001104659-26-092021.md) | [0.26](/filings/0001104659-25-107873.md) | not reported | [0.46](/filings/0001104659-26-057270.md) | [0.43](/filings/0001104659-26-092021.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [14.8](/filings/0001410578-23-002173.md) | [13.8](/filings/0001410578-25-000194.md) | [19.0](/filings/0001410578-24-000611.md) | [16.5](/filings/0001410578-24-001246.md) | [26.4](/filings/0001410578-24-001800.md) | [46.9](/filings/0001104659-26-020655.md) | [56.6](/filings/0001410578-25-001113.md) | [59.8](/filings/0001410578-25-001550.md) | [73.9](/filings/0001104659-25-107873.md) | [82.2](/filings/0001104659-26-092021.md) | [117](/filings/0001104659-26-057270.md) | [240](/filings/0001104659-26-092021.md) |
| Current assets | $m | [29.3](/filings/0001410578-23-002173.md) | [32.1](/filings/0001410578-25-000194.md) | [36.9](/filings/0001410578-24-000611.md) | [38.3](/filings/0001410578-24-001246.md) | [54.8](/filings/0001410578-24-001800.md) | [81.0](/filings/0001104659-26-020655.md) | [92.3](/filings/0001410578-25-001113.md) | [101](/filings/0001410578-25-001550.md) | [120](/filings/0001104659-25-107873.md) | [135](/filings/0001104659-26-092021.md) | [174](/filings/0001104659-26-057270.md) | [321](/filings/0001104659-26-092021.md) |
| Total assets | $m | [56.4](/filings/0001410578-23-002173.md) | [59.4](/filings/0001410578-25-000194.md) | [63.6](/filings/0001410578-24-000611.md) | [66.0](/filings/0001410578-24-001246.md) | [88.2](/filings/0001410578-24-001800.md) | [113](/filings/0001104659-26-020655.md) | [125](/filings/0001410578-25-001113.md) | [133](/filings/0001410578-25-001550.md) | [153](/filings/0001104659-25-107873.md) | [169](/filings/0001104659-26-092021.md) | [210](/filings/0001104659-26-057270.md) | [357](/filings/0001104659-26-092021.md) |
| Current liabilities | $m | [22.9](/filings/0001410578-23-002173.md) | [22.9](/filings/0001410578-25-000194.md) | [25.3](/filings/0001410578-24-000611.md) | [26.4](/filings/0001410578-24-001246.md) | [29.8](/filings/0001410578-24-001800.md) | [39.5](/filings/0001104659-26-020655.md) | [39.1](/filings/0001410578-25-001113.md) | [35.1](/filings/0001410578-25-001550.md) | [44.5](/filings/0001104659-25-107873.md) | [50.5](/filings/0001104659-26-092021.md) | [69.8](/filings/0001104659-26-057270.md) | [186](/filings/0001104659-26-092021.md) |
| Total liabilities | $m | [34.3](/filings/0001410578-23-002173.md) | [34.4](/filings/0001410578-25-000194.md) | [36.7](/filings/0001410578-24-000611.md) | [37.7](/filings/0001410578-24-001246.md) | [41.2](/filings/0001410578-24-001800.md) | [50.1](/filings/0001104659-26-020655.md) | [49.8](/filings/0001410578-25-001113.md) | [46.0](/filings/0001410578-25-001550.md) | [55.7](/filings/0001104659-25-107873.md) | [61.5](/filings/0001104659-26-092021.md) | [82.2](/filings/0001104659-26-057270.md) | [197](/filings/0001104659-26-092021.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [22.9](/filings/0001410578-24-001800.md) | [25.7](/filings/0001410578-25-000194.md) | [27.6](/filings/0001410578-24-001800.md) | [29.0](/filings/0001410578-24-001800.md) | [47.7](/filings/0001410578-24-001800.md) | [63.5](/filings/0001104659-26-020655.md) | [75.5](/filings/0001410578-25-001113.md) | [86.7](/filings/0001410578-25-001550.md) | [97.3](/filings/0001104659-25-107873.md) | [107](/filings/0001104659-26-092021.md) | [128](/filings/0001104659-26-057270.md) | [160](/filings/0001104659-26-092021.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.6 d](/filings/0001410578-24-001800.md) | [0.1 d](/filings/0001410578-25-000194.md) | [6.8](/filings/0001410578-25-001113.md) | [(0.5) d](/filings/0001410578-25-001550.md) | [11.4 d](/filings/0001104659-25-107873.md) | [17.2 d](/filings/0001104659-26-020655.md) | [10.8](/filings/0001104659-26-057270.md) | [4.2 d](/filings/0001104659-26-092021.md) | [18.9 d](/filings/0001104659-25-107873.md) | [12.9 d](/filings/0001104659-26-020655.md) | [37.3](/filings/0001104659-26-057270.md) | [127 d](/filings/0001104659-26-092021.md) |
| Capital expenditure | $m | [1.3 d](/filings/0001410578-24-001800.md) | [1.2 d](/filings/0001410578-25-000194.md) | [1.3](/filings/0001410578-25-001113.md) | [2.7 d](/filings/0001410578-25-001550.md) | [1.5 d](/filings/0001104659-25-107873.md) | [2.2 d](/filings/0001104659-26-020655.md) | [2.4](/filings/0001104659-26-057270.md) | [1.7 d](/filings/0001104659-26-092021.md) | [4.2 d](/filings/0001104659-25-107873.md) | [2.8 d](/filings/0001104659-26-020655.md) | [2.4](/filings/0001104659-26-057270.md) | [2.9 d](/filings/0001104659-26-092021.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [27.3](/filings/0001410578-23-002173.md) | [27.5](/filings/0001410578-24-000611.md) | [27.9](/filings/0001410578-24-001246.md) | [32.5](/filings/0001410578-24-001800.md) | [32.2](/filings/0001410578-25-001113.md) | [28.9](/filings/0001410578-25-001550.md) | [34.0](/filings/0001104659-25-107873.md) | [35.0](/filings/0001104659-26-057270.md) | [35.3](/filings/0001104659-26-092021.md) | [35.3](/filings/0001104659-25-107873.md) | [35.6](/filings/0001104659-26-057270.md) | [34.8](/filings/0001104659-26-092021.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 34,382,651 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001104659-26-092021.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.